Option Care Health (NASDAQ:OPCH) Stock Dropped to Neutral by JPMorgan Chase & Co.

Option Care Health (NASDAQ:OPCH) was downgraded by investment analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a report issued on Wednesday, October 7th, Benzinga reports. They currently have a $33.00 price target on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 5.47% from the company’s previous close.

Several other analysts have also issued reports on OPCH. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and upped their price target for the company from $28.00 to $32.05 in a research report on Tuesday, October 6th. UBS Group reissued a “buy” rating on shares of Option Care Health in a report on Tuesday, September 22nd. William Blair cut Option Care Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, October 6th. Truist Financial set a $32.05 price objective on shares of Option Care Health in a research report on Wednesday, October 7th. Finally, Barrington Research lowered Option Care Health from an “outperform” rating to a “hold” rating in a research report on Wednesday, October 7th. Two research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, Option Care Health currently has an average rating of “Hold” and a consensus target price of $29.48.

Option Care Health Price Performance

Shares of OPCH remained flat at $31.29 during mid-day trading on Wednesday. 2,839,521 shares of the stock traded hands, compared to its average volume of 2,931,649. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The company has a market cap of $4.69 billion, a PE ratio of 23.53, a price-to-earnings-growth ratio of 1.90 and a beta of 0.58. The company has a fifty day moving average of $26.02 and a 200-day moving average of $26.47.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the prior year, the business earned $0.41 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. As a group, equities analysts anticipate that Option Care Health will post 1.70 EPS for the current fiscal year.

Institutional Trading of Option Care Health

Several large investors have recently bought and sold shares of OPCH. Reyes Financial Architecture Inc. purchased a new position in Option Care Health during the third quarter valued at approximately $28,000. Harbor Investment Advisory LLC acquired a new position in shares of Option Care Health during the 2nd quarter worth approximately $48,000. Nykredit A S acquired a new position in shares of Option Care Health in the second quarter worth $56,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Option Care Health during the second quarter worth about $66,000. Finally, Nisa Investment Advisors LLC lifted its holdings in shares of Option Care Health by 268.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,955 shares of the company’s stock valued at $66,000 after buying an additional 2,154 shares during the period. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.